GSK is expected to report earnings to rise 97.88% to $1.23 per share on July 28
Q2'26
Est.
$1.23
Q1'26
Missed
by $0.54
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.20
Q2'25
Missed
by $0.71
The last earnings report on April 29 showed earnings per share of 62 cents, missing the estimate of $1.16. With 2.87M shares outstanding, the current market capitalization sits at 103.61B.